211 related articles for article (PubMed ID: 31891797)
1. Actinidia Chinensis Planch Root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting the DLX2/TARBP2/JNK/AKT pathway.
Fang T; Zhao Z; Yuan F; He M; Sun J; Guo M; Huang P; Yang B; Xia J
J Ethnopharmacol; 2020 Apr; 251():112529. PubMed ID: 31891797
[TBL] [Abstract][Full Text] [Related]
2. Actinidia chinensis Planch root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition.
Fang T; Fang Y; Xu X; He M; Zhao Z; Huang P; Yuan F; Guo M; Yang B; Xia J
J Ethnopharmacol; 2019 Mar; 231():474-485. PubMed ID: 30415058
[TBL] [Abstract][Full Text] [Related]
3. Actinidia chinensis Planch root extract (acRoots) inhibits hepatocellular carcinoma progression by inhibiting EP3 expression.
Fang T; Hou J; He M; Wang L; Zheng M; Wang X; Xia J
Cell Biol Toxicol; 2016 Dec; 32(6):499-511. PubMed ID: 27475644
[TBL] [Abstract][Full Text] [Related]
4. Actinidia chinensis Planch root extract inhibits cholesterol metabolism in hepatocellular carcinoma through upregulation of PCSK9.
He M; Hou J; Wang L; Zheng M; Fang T; Wang X; Xia J
Oncotarget; 2017 Jun; 8(26):42136-42148. PubMed ID: 28178673
[TBL] [Abstract][Full Text] [Related]
5.
Zheng Y; Su L; Tan J; Dong F
Bioengineered; 2022 Mar; 13(3):4911-4922. PubMed ID: 35152841
[TBL] [Abstract][Full Text] [Related]
6. Actinidia chinensis Planch. root extract inhibits the proliferation, migration and invasion of breast cancer cells via the AKT/GSK-3β signaling pathway.
Gan C; Jin Z; Wei X; Jin M
Folia Histochem Cytobiol; 2021; 59(4):226-235. PubMed ID: 34852177
[TBL] [Abstract][Full Text] [Related]
7. Exploring the anticancer potential of Actinidia chinensis Planch root extracts (
Qiu K; Xia Q; Chen H; Ye Q; Mao H; Tian M; Gan Y; Huang Q; Wang H; Duan S
Heliyon; 2023 Nov; 9(11):e21851. PubMed ID: 38027882
[TBL] [Abstract][Full Text] [Related]
8. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
9. Regulatory roles of OASL in lung cancer cell sensitivity to Actinidia chinensis Planch root extract (acRoots).
Lv J; Wang L; Shen H; Wang X
Cell Biol Toxicol; 2018 Jun; 34(3):207-218. PubMed ID: 29508110
[TBL] [Abstract][Full Text] [Related]
10. The root of Actinidia chinensis inhibits hepatocellular carcinomas cells through LAMB3.
Hou J; Wang L; Wu D
Cell Biol Toxicol; 2018 Aug; 34(4):321-332. PubMed ID: 29127567
[TBL] [Abstract][Full Text] [Related]
11. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
[TBL] [Abstract][Full Text] [Related]
12. Ophiopogonin‑B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways.
Yuan F; Gao Q; Tang H; Shi J; Zhou Y
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35169857
[TBL] [Abstract][Full Text] [Related]
13. Regulatory roles of HSPA6 in Actinidia chinensis Planch. root extract (acRoots)-inhibited lung cancer proliferation.
Wang L; Hou J; Wang J; Zhu Z; Zhang W; Zhang X; Shen H; Wang X
Clin Transl Med; 2020 Jun; 10(2):e46. PubMed ID: 32508044
[TBL] [Abstract][Full Text] [Related]
14. Actinidia chinensis Planch prevents proliferation and migration of gastric cancer associated with apoptosis, ferroptosis activation and mesenchymal phenotype suppression.
Gao Z; Deng G; Li Y; Huang H; Sun X; Shi H; Yao X; Gao L; Ju Y; Luo M
Biomed Pharmacother; 2020 Jun; 126():110092. PubMed ID: 32203890
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer effects of ethanol extract of Reynoutria japonica Houtt. radix in human hepatocellular carcinoma cells via inhibition of MAPK and PI3K/Akt signaling pathways.
Kim BR; Ha J; Lee S; Park J; Cho S
J Ethnopharmacol; 2019 Dec; 245():112179. PubMed ID: 31445130
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
[TBL] [Abstract][Full Text] [Related]
17. TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma.
Lai HH; Li CW; Hong CC; Sun HY; Chiu CF; Ou DL; Chen PS
Mol Oncol; 2019 Apr; 13(4):928-945. PubMed ID: 30657254
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of DLX2 is associated with poor prognosis and sorafenib resistance in hepatocellular carcinoma.
Liu J; Cui X; Qu L; Hua L; Wu M; Shen Z; Lu C; Ni R
Exp Mol Pathol; 2016 Aug; 101(1):58-65. PubMed ID: 27302463
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465
[TBL] [Abstract][Full Text] [Related]
20. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.
Yuan S; Gong Y; Chen R; Du J; Zhang H; Chen T
Biomed Pharmacother; 2020 Dec; 132():110867. PubMed ID: 33075668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
